Can you get cancer from flying?September 18, 2000Air personnel may be exposed to a higher dose of radiation than earlier calculated, and the risk for cancer may be underestimated. This conclusion is presented by research student Somsak Dangtip in his PhD thesis at Uppsala University, Sweden. His findings are based on new evidence from experiments at the The Svedberg Laboratory. It is wellknown that airfare crew get higher radiation doses than medical X-ray personnel, due to cosmic rays. Recently, it has also been reported that personnel onboard airplanes experience increased risk for some types of cancer tumors. It is, however, difficult to know exactly how big the problem is, and how severe damages the radiation from space actually causes. In his PhD thesis, Somsak Dangtip of Department of Neutron Research shows that these effects might be an even larger problem than previously anticipated. Experiments at the The Svedberg Laboratory at Uppsala university, Sweden, reveals that the nuclear reactions, which ultimately causes tumors, might be significantly underestimated. For these experiments, a new facility for measuring nuclear cross sections, has been built. The equipment serves multi purposes: i.e. to study methods for cancer treatments, for studies relevant for destruction of nuclear waste and nuclear weapons, and to make electronics less sensitive to radiation. The risk of having cancer links to the radiation dose. At high flight altitudes, neutrons are the dominating source of radiation. The energy of the neutrons varies, from very low to high energies. Radiation doses can be measured, either by direct measurement or through theoretical calculations. In the low energy region both methods agree, and assess well a dose estimation. In the high energy region where no direct measurement has been done earlier, one has been forced to rely on calculations. Somsak Dangtips findings show that in the high energy region, where no data existed before, radiation doses from neutrons, obtained from calculations, has been underestimated. The title of the thesis is “Experimental Studies of Neutron-Induced Reactions in Light Nuclei”, and it will be publicly examined on September 22. Faculty Opponent is Professor Jean-Pierre Meulders from Universite Catholique de Louvain, Belgium. Somsak Dangtip e-mail address: somsak.dangtip@tsl.uu.se Cambridge, University of |
|||||||||||||||||||||
| Related Cancer Current Events and Cancer News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Other Illnesses, Body Weight Do Not Explain Racial Disparities in Colon Cancer Survival, UAB Researchers Say A new study by University of Alabama at Birmingham (UAB) researchers shows that body-mass index (BMI) and co-existing medical conditions (co-morbidity) do not explain the decreased survival observed among African-Americans compared to Caucasians who also have colon cancer. Multiple health concerns surface as winter, vitamin D deficiences arrive A string of recent discoveries about the multiple health benefits of vitamin D has renewed interest in this multi-purpose nutrient, increased awareness of the huge numbers of people who are deficient in it, spurred research and even led to an appreciation of it as "nature's antibiotic." AIDS research reveals a lack of family-planning programs in Uganda University of Alberta graduate student Jennifer Heys wants to make her message clear: there needs to be more education in Ugandan communities about contraception. Possible Link Studied Between Childhood Abuse and Early Cellular Aging Children who suffer physical or emotional abuse may be faced with accelerated cellular aging as adults, according to new research from Butler Hospital and Brown University. Rare pancreatic cancer patients may live longer when treated with radiation therapy Radiation therapy is effective in achieving local control and palliation in patients with pancreatic neuroendocrine tumors (PNTs), despite such tumors being commonly considered resistant to radiation therapy. Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. Saving the single cysteine: new antioxidant system found We've all read studies about the health benefits of having a life partner. The same thing is true at the molecular level, where amino acids known as cysteines are much more vulnerable to damage when single than when paired up with other cysteines. Gene mismatch influences success of bone marrow transplants A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics. Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. More Cancer Current Events and Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||